Concepts (59)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Paraventricular Hypothalamic Nucleus | 2 | 2018 | 8 | 1.210 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2018 | 36 | 1.190 |
Why?
|
| Heart Rate | 3 | 2020 | 315 | 0.890 |
Why?
|
| Autonomic Nervous System | 1 | 2020 | 42 | 0.720 |
Why?
|
| Amyloidosis | 1 | 2019 | 10 | 0.690 |
Why?
|
| Heart | 1 | 2020 | 162 | 0.680 |
Why?
|
| Receptor, trkB | 1 | 2018 | 2 | 0.660 |
Why?
|
| Stress, Psychological | 1 | 2018 | 210 | 0.560 |
Why?
|
| Cognition | 1 | 2020 | 526 | 0.550 |
Why?
|
| Alzheimer Disease | 1 | 2019 | 312 | 0.520 |
Why?
|
| Solitary Nucleus | 1 | 2015 | 34 | 0.520 |
Why?
|
| Endocannabinoids | 1 | 2015 | 34 | 0.520 |
Why?
|
| Baroreflex | 1 | 2015 | 84 | 0.500 |
Why?
|
| Angiotensin II | 1 | 2016 | 279 | 0.490 |
Why?
|
| Heart Failure | 1 | 2019 | 571 | 0.450 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2018 | 747 | 0.370 |
Why?
|
| Aging | 1 | 2015 | 881 | 0.330 |
Why?
|
| Age Factors | 2 | 2020 | 1110 | 0.250 |
Why?
|
| Blood Pressure | 2 | 2016 | 807 | 0.200 |
Why?
|
| Animals | 3 | 2018 | 7302 | 0.190 |
Why?
|
| Male | 4 | 2020 | 17872 | 0.180 |
Why?
|
| Prealbumin | 1 | 2019 | 8 | 0.170 |
Why?
|
| Mental Health | 1 | 2020 | 104 | 0.170 |
Why?
|
| Neuropsychological Tests | 1 | 2020 | 379 | 0.170 |
Why?
|
| Memory | 1 | 2020 | 187 | 0.160 |
Why?
|
| Rats, Transgenic | 1 | 2018 | 52 | 0.160 |
Why?
|
| Health Status | 1 | 2020 | 369 | 0.160 |
Why?
|
| Eating | 1 | 2018 | 73 | 0.150 |
Why?
|
| Sympathetic Nervous System | 1 | 2016 | 29 | 0.140 |
Why?
|
| Prognosis | 1 | 2020 | 1363 | 0.140 |
Why?
|
| Cardiovascular System | 1 | 2016 | 39 | 0.140 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2016 | 68 | 0.140 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 1365 | 0.140 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2016 | 75 | 0.140 |
Why?
|
| Vasoconstrictor Agents | 1 | 2016 | 62 | 0.130 |
Why?
|
| Glycerides | 1 | 2015 | 13 | 0.130 |
Why?
|
| Electrocardiography | 1 | 2020 | 568 | 0.130 |
Why?
|
| Microinjections | 1 | 2015 | 33 | 0.130 |
Why?
|
| Arachidonic Acids | 1 | 2015 | 23 | 0.130 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2016 | 134 | 0.130 |
Why?
|
| Receptor, Cannabinoid, CB2 | 1 | 2015 | 16 | 0.130 |
Why?
|
| Pyrazoles | 1 | 2015 | 65 | 0.130 |
Why?
|
| Mass Spectrometry | 1 | 2015 | 100 | 0.130 |
Why?
|
| Prospective Studies | 1 | 2020 | 2027 | 0.130 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2015 | 51 | 0.130 |
Why?
|
| Time Factors | 1 | 2020 | 2003 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 248 | 0.130 |
Why?
|
| Signal Transduction | 1 | 2018 | 666 | 0.120 |
Why?
|
| Piperidines | 1 | 2015 | 125 | 0.120 |
Why?
|
| RNA, Messenger | 1 | 2015 | 514 | 0.110 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 481 | 0.110 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 3726 | 0.110 |
Why?
|
| Brain | 1 | 2019 | 930 | 0.100 |
Why?
|
| United States | 1 | 2020 | 3648 | 0.100 |
Why?
|
| Hypertension | 1 | 2016 | 912 | 0.080 |
Why?
|
| Humans | 2 | 2020 | 29213 | 0.080 |
Why?
|
| Aged | 1 | 2020 | 9510 | 0.070 |
Why?
|
| Middle Aged | 1 | 2020 | 10868 | 0.070 |
Why?
|
| Female | 1 | 2020 | 18236 | 0.050 |
Why?
|